EOM Pharmaceuticals Holdings, Inc. (OTCMKTS:IMUC – Get Rating) fell 3.1% during trading on Monday . The company traded as low as $0.25 and last traded at $0.34. 216 shares changed hands during mid-day trading, a decline of 93% from the average session volume of 2,938 shares. The stock had previously closed at $0.35.
EOM Pharmaceuticals Stock Down 3.1 %
The stock has a fifty day moving average of $0.44 and a 200 day moving average of $0.64.
EOM Pharmaceuticals Company Profile
EOM Pharmaceuticals Holdings, Inc is a clinical-stage pharmaceutical company focused on the development of novel therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its development pipeline consists of multiple programs and clinical indications at various stages of development.
Featured Stories
- Get a free copy of the StockNews.com research report on EOM Pharmaceuticals (IMUC)
- Medtronic: Reversal In-Play For This High-Yield Stock
- Is it ‘Game Over’ for Roblox After Reporting March Metrics Miss?
- Is it Time to Take Profits in Chip Stocks?
- Will Stratasys Continue to be a Runaway Bride?
- Garrett Motion Inc. Skids on Results: Is it Time to Buy the Dip?
Receive News & Ratings for EOM Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EOM Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
